Human medicines European Public Assessment Report (EPAR): Vivanza, vardenafil, Revision: 15, Authorised
Related Biotechnology, Pharmaceutical and Healthcare News
- Human medicines European Public Assessment Report (EPAR): Incivo, telaprevir, Revision: 7, Authorised
- Human medicines European Public Assessment Report (EPAR): Incivo, telaprevir, Revision: 6, Authorised
- Human medicines European Public Assessment Report (EPAR): Lyrica, pregabalin, Revision: 22, Authorised
- Human medicines European Public Assessment Report (EPAR): Neulasta, pegfilgrastim, Revision: 19, Authorised
- Human medicines European Public Assessment Report (EPAR): Qutenza, capsaicin, Revision: 7, Authorised
Original Article: Human medicines European Public Assessment Report (EPAR): Vivanza, vardenafil, Revision: 15, Authorised
NEXT ARTICLE
More From BioPortfolio on "Human medicines European Public Assessment Report (EPAR): Vivanza, vardenafil, Revision: 15, Authorised"
Search BioPortfolio: